Merida Biosciences
Reut Brauner is an accomplished finance professional with extensive experience in accounting and financial management. Currently serving as Senior Director and Controller at Merida Biosciences since June 2025, Reut previously held similar roles at Abata Therapeutics from November 2021 to May 2025 and at Mersana Therapeutics from October 2017 to August 2021. Reut's earlier positions include Accounting Manager at H.C. Starck, Manager of Group Controlling at PALRAM Industries, and a significant role as a board member at Milouof Agricultural Cooperative, LTD. Reut's career began at KPMG Israel in the Assurance Practice. Academic credentials include an M.B.A. in Finance from Tel Aviv University and a CPA from Ruppin Academic Center, complemented by a Bachelor's degree in Accounting and Economics from the same institution.
This person is not in any teams
This person is not in any offices
Merida Biosciences
Merida Biosciences is a biotechnology company pioneering a new class of precision therapeutics designed to selectively and durably eliminate pathogenic antibodies that drive disease. The company is advancing a robust pipeline to precisely eliminate the root cause of multiple autoimmune and allergic conditions that are inadequately treated today. Its lead program is designed to specifically and rapidly clear the pathogenic autoantibodies that cause Graves' disease, an autoimmune disorder that affects the thyroid gland. Merida was publicly launched in April 2025 and is based in Cambridge, MA. For more information about Merida, visit www.meridabio.com.